CLPT Relative Valuation
CLPT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CLPT is overvalued; if below, it's undervalued.
Historical Valuation
Clearpoint Neuro Inc (CLPT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -17.83. The fair price of Clearpoint Neuro Inc (CLPT) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：14.03
Fair
-16.94
PE
1Y
3Y
5Y
Trailing
Forward
-26.51
EV/EBITDA
Clearpoint Neuro Inc. (CLPT) has a current EV/EBITDA of -26.51. The 5-year average EV/EBITDA is -23.86. The thresholds are as follows: Strongly Undervalued below -50.28, Undervalued between -50.28 and -37.07, Fairly Valued between -10.66 and -37.07, Overvalued between -10.66 and 2.55, and Strongly Overvalued above 2.55. The current Forward EV/EBITDA of -26.51 falls within the Historic Trend Line -Fairly Valued range.
-18.20
EV/EBIT
Clearpoint Neuro Inc. (CLPT) has a current EV/EBIT of -18.20. The 5-year average EV/EBIT is -16.36. The thresholds are as follows: Strongly Undervalued below -34.64, Undervalued between -34.64 and -25.50, Fairly Valued between -7.22 and -25.50, Overvalued between -7.22 and 1.92, and Strongly Overvalued above 1.92. The current Forward EV/EBIT of -18.20 falls within the Historic Trend Line -Fairly Valued range.
8.01
PS
Clearpoint Neuro Inc. (CLPT) has a current PS of 8.01. The 5-year average PS is 11.38. The thresholds are as follows: Strongly Undervalued below -0.77, Undervalued between -0.77 and 5.30, Fairly Valued between 17.45 and 5.30, Overvalued between 17.45 and 23.53, and Strongly Overvalued above 23.53. The current Forward PS of 8.01 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Clearpoint Neuro Inc. (CLPT) has a current P/OCF of 0.00. The 5-year average P/OCF is -20.54. The thresholds are as follows: Strongly Undervalued below -71.49, Undervalued between -71.49 and -46.01, Fairly Valued between 4.93 and -46.01, Overvalued between 4.93 and 30.41, and Strongly Overvalued above 30.41. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Clearpoint Neuro Inc. (CLPT) has a current P/FCF of 0.00. The 5-year average P/FCF is -30.49. The thresholds are as follows: Strongly Undervalued below -88.51, Undervalued between -88.51 and -59.50, Fairly Valued between -1.48 and -59.50, Overvalued between -1.48 and 27.52, and Strongly Overvalued above 27.52. The current Forward P/FCF of 0.00 falls within the Overvalued range.
Clearpoint Neuro Inc (CLPT) has a current Price-to-Book (P/B) ratio of 25.22. Compared to its 3-year average P/B ratio of 11.08 , the current P/B ratio is approximately 127.51% higher. Relative to its 5-year average P/B ratio of 35.05, the current P/B ratio is about -28.06% higher. Clearpoint Neuro Inc (CLPT) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -6.43%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -5.51% , the current FCF yield is about -100.00% lower.
25.18
P/B
Median3y
11.08
Median5y
35.05
-3.45
FCF Yield
Median3y
-6.43
Median5y
-5.51
Competitors Valuation Multiple
The average P/S ratio for CLPT's competitors is , providing a benchmark for relative valuation. Clearpoint Neuro Inc Corp (CLPT) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 9.10%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of CLPT decreased by 8.58% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 8.12M to 8.86M.
The secondary factor is the Margin Expansion, contributed 8.56%to the performance.
Overall, the performance of CLPT in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Clearpoint Neuro Inc (CLPT) currently overvalued or undervalued?
What is Clearpoint Neuro Inc (CLPT) fair value?
How does CLPT's valuation metrics compare to the industry average?
What is the current P/B ratio for Clearpoint Neuro Inc (CLPT) as of Dec 05 2025?
What is the current FCF Yield for Clearpoint Neuro Inc (CLPT) as of Dec 05 2025?
What is the current Forward P/E ratio for Clearpoint Neuro Inc (CLPT) as of Dec 05 2025?